BTIG analyst Thomas Shrader raised the price target on Harrow Health (NASDAQ: HROW) to $63.00 (from $62.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE